Navigation Links
Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
Date:2/22/2008

Primary Endpoint of the Trial to Be Clarified with FDA

WALTHAM, Mass., Feb. 22 /PRNewswire-FirstCall/ -- Arbios Systems, Inc. (OTC Bulletin Board: ABOS) announced today that the Company has received conditional approval from the U.S. Food and Drug Administration ("FDA") of an Investigational Device Exemption ("IDE") to begin the pivotal clinical trial for SEPET(TM), Arbios' extracorporeal (outside the body) artificial liver assist device for blood purification of chronically ill patients suffering from acute liver failure. Permission was granted to initiate the trial while the Company responds to the FDA's conditions and request for additional information. In particular, FDA has requested a survival primary endpoint, which could potentially increase the total number of patients required for the trial. The trial design proposed by the Company has a primary endpoint of a two-stage drop in hepatic encephalopathy and its secondary endpoints include several survival based endpoints. The Company is refining its position that a two-stage drop in hepatic encephalopathy is clinically meaningful and an appropriate primary endpoint for the trial. The Company is requesting a meeting with FDA to discuss this issue and to confirm the overall design of the trial.

"While we are pleased to have received FDA permission to start the SEPET pivotal trial, we will work diligently with FDA with the hope of identifying a mutually acceptable primary endpoint," commented CEO and President Shawn Cain. "We currently do not have the financial resources to fund the pivotal trial and our ability to finance the Company is contingent upon, among other issues, agreement on a primary endpoint with a reasonable number of patients required for the trial."

"Hepatic encephalopathy ("HE") represents one of the most frequent complications of cirrhosis mandating hospitalization and a two-stage improvement of HE has significant clinical benefits to patients," noted Dr. John
'/>"/>

SOURCE Arbios Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced ... Investor Conference Call and webcast at 4:30 p.m., Eastern time, ... cover an update on Merrimack,s progress as well as ... release detailing the information to be discussed on the ... 10. Investors and the general public are invited to ...
(Date:8/3/2015)... PARK, N.J. , Aug. 3, 2015 ... and secondary endpoints in a phase III study (COMPOSE ... adult patients with chronic non-cancer pain. Naldemedine is an ... is the third Phase III trial in which naldemedine ... Study results showed that a 0.2 mg tablet of ...
(Date:8/3/2015)... LEXINGTON, Massachusetts , August 3, 2015 /PRNewswire/ ... SHPG ) announced today that it has ... held Foresight Biotherapeutics Inc. for $300 million. With ... FST-100 (topical ophthalmic drops combining 0.6% povidone iodine ... development for the treatment of infectious conjunctivitis, an ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6
... Nov. 29 Dr. Christine Cassel,expert and author ... has,been named a member of the Alzheimer,s Study ... former Speaker of the House Newt Gingrich and,former ... President and Chief Executive Officer of the American,Board ...
... Getty Images, ,Change Me, Initiative Raised Worldwide Awareness and Funds ... to Fight Aids, Tuberculosis and ... the world,s leading imagery creator and distributor, today announced,the successful ... used powerful images to share their thoughts on how to ...
Cached Medicine Technology:American Board of Internal Medicine President Named to Alzheimer's Study Group 2Getty Images Celebrates Conclusion of 'Change Me' Imagery Forum 2Getty Images Celebrates Conclusion of 'Change Me' Imagery Forum 3
(Date:8/3/2015)... ... 03, 2015 , ... The art of preparing and cooking food comes naturally ... a young age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that ... from My Persian Kitchen with the world. , Since Americans tend to be undereducated ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... the development of it’s new program “Designing Secure Healthcare Systems” This three-day, ... and technology leaders from healthcare organizations with access to the tactics, techniques and ...
(Date:8/3/2015)... Angeles, CA (PRWEB) , ... August 03, 2015 , ... ... has emerged among U.S. emergency rooms in recent years, according to the American Dental ... the number of dental emergency visits went from 1.1 million in a single year ...
(Date:8/3/2015)... ... August 03, 2015 , ... Illinois Health & Science (IHS) has completed the ... acquisition includes all of IBAM NA’s cyclotron sites and research and development facilities. ... located business, as well as a large manufacturing hub in Noblesville, Indiana,” said Ken ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Constantin Vasilica, ... accompanied by tissue injury caused by diabetes after many years of suffering and using ... times, and he didn’t want to ask for extra time off or wait longer ...
Breaking Medicine News(10 mins):Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
... Device "Rewires" Brain, Improves and Restores Balance, Normal Walking , ... ... on, "virtual reality" has a whole new meaning for people with ... walk normally again., , , , ,The GaitAid Virtual Walker, a ...
... that promises to one day allow drug delivery to be ... researchers at the University of California, San Diego School of ... primary cells. The work will be published in the May ... . , "RNAi has an unbelievable potential to manage cancer ...
... Dame warns TV networks that they will "cut the ... on Sunday.Dr. Alan Keyes to be available soon for interview ... 5 pro-lifers that have been held in jail without bond. ... The Following is Being Issued by Randall Terry, Founder of ...
... factors to help decide how aggressive therapy should be ... claim to have found a way to better customize ... that can help predict how long men could survive ... from the Duke Comprehensive Cancer Center, who say such ...
... 2 new deaths, may not reflect true reach of the ... the official tally of confirmed U.S. swine flu cases topped ... and Prevention now estimate the true number of infections at ... announced two new deaths linked to the H1N1 virus, bringing ...
... National Fertility Link is Helping Infertile Men and Women Find the ... Resources from Fertility Clinics Through Technology. , ... (PRWEB) ... nation wide resource for couples that are struggling to be pregnant. ...
Cached Medicine News:Health News:New Hope for Walking Normally, Living Better With Cerebral Palsy 2Health News:The future of personalized cancer treatment: An entirely new direction for RNAi delivery 2Health News:18 More Anti-Abortion Activists Arrested at Notre Dame on Saturday; More Arrests Planned for Sunday 2Health News:An Aid to Tailoring Prostate Cancer Treatment 2Health News:Swine Flu May Have Infected More Than 100,000 Americans 2Health News:Swine Flu May Have Infected More Than 100,000 Americans 3Health News:Swine Flu May Have Infected More Than 100,000 Americans 4Health News:Swine Flu May Have Infected More Than 100,000 Americans 5Health News:Swine Flu May Have Infected More Than 100,000 Americans 6Health News:Swine Flu May Have Infected More Than 100,000 Americans 7Health News:Swine Flu May Have Infected More Than 100,000 Americans 8Health News:Swine Flu May Have Infected More Than 100,000 Americans 9Health News:Swine Flu May Have Infected More Than 100,000 Americans 10Health News:Swine Flu May Have Infected More Than 100,000 Americans 11Health News:Swine Flu May Have Infected More Than 100,000 Americans 12Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 2Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 3
Acuity Astigmatism: Letter Acuity, Astigmatic Clock, Number Acuity, and Tumbling E Tests....
... laboratory analysis that measures a substance produced by ... Annual PSA testing is a safe and effective ... as prostate cancer. One BIOSAFE Collection Kit, ... BIOSAFE's CLIA Certified Laboratory, and review of results ...
Stereo Smile II also includes a blank card and tests,at 60, 120, 240 and 480 sec of arc., ,Smile Test II Includes:, 1 demonstration card, 1 pair pediatric 3-D viewers, 1 pair infant 3-D v...
... from 800 to 40 seconds ... as 2 years of age ... left to right., ,Randot Preschool ... #1: 200 & 100 sec ...
Medicine Products: